The National Cancer Institute has made clinical trial participation a top national priority and yet participant levels are still not perhaps where they could be. Yes, this is a big decision for any patient/physician to make as far as whether or not to enroll, but many trials are offering lifesaving...
Posted to
The Medical Quack .... by Barbara Duck
on 11-02-2008
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Investors, health insurance, Pharma, Cancer, clinical trials, HMO, Pharmaceuticals, R and D, Drug Development, Cancer Institute
We all may complain and wonder about the processes of the FDA, but when you read stories like this one, it does make you wonder about the research and development in other countries and how thorough the process is, this in light of all the contaminated milk products on the market as well coming from...
The company has 6 months to get the shares up above $1.00 or it goes to the junk category and off the big board. Drug stores are feeling the pinch of the economic slow down, depending on where the stood financially before hand, has an effect on where they are today. Granted Rite Aid had some...
Posted to
The Medical Quack .... by Barbara Duck
on 10-17-2008
Filed under: Medically Related, Insurance, Pharma/FDA News, drugs, healthcare, Prescriptions, Pharmaceuticals, Stocks, Rite Aid
This article states part of the reporting system will include information on the willingness of a doctor to use genetic testing, well first of all we need to help the doctors to bring this full circle with the integration into the clinical side of this, as I have spoken to many MDs and they are aware...
Posted to
The Medical Quack .... by Barbara Duck
on 10-06-2008
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Education, FDA, Pharmaceuticals, Pharmacogenomics, DNA Testing
New marketing technique going on here, gets you to the website, but no mention of the drug name . This ranks right up there with the Placebo ads from the FDA for a fake blood pressure pill , and what website will it take you to? Is there any honestly or dignity left in advertising? ...
This article brings up a good point, when a patient has no other choices and the potential of a new drug could offer some relief, what is the verdict at this point? The FDA has turned it's way of thinking around now to being much more conservative on the drugs that are approved. Do the drug companies...
Part of the success of Amgen was using a smaller amount of individuals for clinical trials, and looking at results during the trial instead of an overall evaluation process at the conclusion. It also helps keep the cost of the clinical trials down by conducting studies for biomarkers, or signature...